Dr. Timothy Behrens moved to Genentech in 2006 following 20+ years in academia, with a focus on three major themes: 1) development of B lymphocytes; 2) genetics of human autoimmune diseases, especially systemic lupus erythematosus; and 3) identification of biomarkers for lupus and rheumatoid arthritis. Recently, Dr. Behrens has been particularly intrigued by the problem of applying cutting-edge genetic and proteomic technologies into the clinic to answer important questions like 'How active is the disease in this patient?' and 'How likely is this patient to respond to a particular drug?'

 

In addition to his work at Genentech, Dr. Behrens is an Adjunct Professor of Medicine at the University of Minnesota Medical School, where he previously was the head of the Autoimmunity Center.